Compugen Ltd (NASDAQ: CGEN) kicked off on Tuesday, up 6.45% from the previous trading day, before settling in for the closing price of $1.55. Over the past 52 weeks, CGEN has traded in a range of $1.13-$2.66.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 18.03%. While this was happening, its average annual earnings per share was recorded -87.50%. With a float of $91.64 million, this company’s outstanding shares have now reached $93.54 million.
Compugen Ltd (CGEN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Compugen Ltd is 2.03%, while institutional ownership is 13.62%.
Compugen Ltd (CGEN) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.07 earnings per share (EPS), higher than consensus estimate (set at -0.08) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.79% during the next five years compared to 18.03% growth over the previous five years of trading.
Compugen Ltd (NASDAQ: CGEN) Trading Performance Indicators
Take a look at Compugen Ltd’s (CGEN) current performance indicators. Last quarter, stock had a quick ratio of 4.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.30, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of Compugen Ltd (CGEN)
The latest stats from [Compugen Ltd, CGEN] show that its last 5-days average volume of 0.31 million was inferior to 0.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 48.93%.
During the past 100 days, Compugen Ltd’s (CGEN) raw stochastic average was set at 32.72%, which indicates a significant decrease from 72.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0886 in the past 14 days, which was lower than the 0.0958 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6965, while its 200-day Moving Average is $1.5601. Now, the first resistance to watch is $1.7433. This is followed by the second major resistance level at $1.8365. The third major resistance level sits at $1.9532. If the price goes on to break the first support level at $1.5334, it is likely to go to the next support level at $1.4167. The third support level lies at $1.3235 if the price breaches the second support level.
Compugen Ltd (NASDAQ: CGEN) Key Stats
The company with the Market Capitalisation of 154.33 million has total of 89,237K Shares Outstanding. Its annual sales at the moment are 27,860 K in contrast with the sum of -14,230 K annual income. Company’s last quarter sales were recorded 1,890 K and last quarter income was -6,980 K.
